Purdue Pharma L.P. is a privately held pharmaceutical company owned principally by descendants of Mortimer and Raymond Sackler. In 2007, it paid out one of the largest fines ever levied against a pharmaceutical firm for mislabeling its product OxyContin, and three executives were found guilty of criminal charges. Although the company shifted its focus to abuse-deterrent formulations, Purdue continued to market and sell opioids, and continued to be involved in lawsuits around the opioid epidemic in the United States. Purdue filed for Chapter 11 bankruptcy protection on September 15, 2019 in New York.
OxyContin maker Purdue Pharma LP won a court order on Friday briefly pausing the sprawling opioid litigation against the company so it can try to make headway on its proposed legal settlement that it.. Reuters - Published
A U.S. Bankruptcy Judge signaled support on Friday for a six-month pause to litigation led by 24 states against OxyContin maker Purdue Pharma LP to give the company time to settle thousands of lawsuits.. Reuters - Published
Purdue Pharma, the company behind OxyContin, filed for bankruptcy protection Sunday night (September 15), amid more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic...
OxyContin maker Purdue Pharma reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states..
Oklahoma Attorney General Mike Hunter slammed Johnson & Johnson as the "kingpin behind the nation's ongoing opioid crisis" moments after a judge ruled against the drugmaker and ordered it to pay $572..
The U.S. state of Arizona withdrew its support for a proposed nationwide opioid settlement with Purdue Pharma LP, saying the maker of OxyContin sought to "undermine material terms of the deal,".. Reuters - Published
OxyContin maker Purdue Pharma LP steered up to $13 billion in profits to the company's controlling Sackler family, according to U.S. states opposing efforts to halt lawsuits alleging the company and.. Reuters - Published
U.S. state officials are due on Friday to launch a counterattack against OxyContin maker Purdue Pharma LP over its attempt to shield the company and its controlling Sackler family from thousands of.. Reuters - Published
Lawyers for the pharmaceutical company secured permission to maintain business as usual — paying employees and vendors, supplying pills to distributors and keeping current on taxes and insurance CBS News - Published
A judge heard arguments to decide whether lawsuits against members of the Sackler family that owns Purdue Pharma can go ahead with the company seeking bankruptcy protection. (Sept. 17)
USATODAY.com - Published
Vanity Fair contributing editor Bethany McClean joined CBSN to discuss her reporting on Purdue Pharma and its involvement in the opioid epidemic. She interviewed David Sackler, who says his family did.. CBS News - Published
Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy late Sunday. The move came days after Purdue reached a tentative settlement with many.. CBS News - Published
President Trump proposes a ban on most flavored vaping products. Also, 23 states have reached a tentative settlement with OxyContin maker Purdue Pharma over the nation’s opioid crisis. All that and.. CBS News - Published
A government source tells CBS News the maker of oxycontin could file for bankruptcy as early as Wednesday. Purdue Pharma and its owners, members of the Sackler family, have been negotiating a potential.. CBS News - Published
The billionaire Sackler family may be willing to pay up, to settle thousands of lawsuits stemming from the opioid crisis. The proposed settlement comes amid speculation that the family's company,.. CBS News - Published
The U.S. judge overseeing nationwide litigation concerning the opioid epidemic on Monday rejected Purdue Pharma LP's effort to dismiss claims that its activities caused a public nuisance. Reuters - Published
The U.S. judge overseeing nationwide litigation concerning the opioid crisis on Monday rejected Purdue Pharma LP's effort to dismiss claims that its activities caused a public nuisance. Reuters - Published
Washington Post reporter Lenny Bernstein joins CBSN to discuss his reporting on a proposed Purdue Pharma settlement could leave the Sackler family with most of their personal fortune. CBS News - Published
Puerto Rico braces for Tropical Storm Dorian. Also, Purdue Pharma is offering $10 to 12 billion to settle more than 2,000 lawsuits accusing them of fueling the opioid crisis. All that and all that.. CBS News - Published
CBS News has learned Purdue Pharma, the maker of oxycontin is offering to pay billions of dollars to settle thousands of lawsuits stemming from the opioid crisis. Newly obtained video also shows the.. CBS News - Published Also reported by •Reuters
CBS News has learned Purdue Pharma, the maker of OxyContin, has offered $5-6 billion to settle thousands of claims. It is unclear how much Purdue's owners, the Sackler family, would have to pay. CBS News - Published
OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar.. Reuters - Published
OxyContin maker Purdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, NBC News reported on Tuesday,.. Reuters - Published
The Times TV show’s producer/director shares the challenges and rewards of bringing to life witness testimony against Purdue Pharma in a way that stayed true to our journalistic principles. NYTimes.com - Published
Museums and universities are cutting ties with the Sackler family amid lawsuits against them and the company they run, Purdue Pharma. They're accused of engaging in aggressive marketing tactics for the.. CBS News - Published
With Purdue Pharma and Teva settling the case, the state sought to hold J & J responsible for the broader opioid crisis. The company argued that it operated responsibly and lawfully. NYTimes.com - Published